Psychoneurobiology

 

 

Antila E, Westermark T, On the etiopathogenesis and therapy of Down syndrome. Int. J. Dev. Biol. 33: 183-188, 1989 Medline

Baez S, Segura-Aguilar J, Widersten M, et al. Glutathione transferases catalyze the detoxification of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem. J. 324 (pt.1): 25-28, 1997 Medline

Bandmann O, Vaughen J, Holmans P, et al. Association of slow acetylator genotype for N-acetyltransferase 2 with familiar Parkinson’s disease. Lancet 350: 1136-1139, 1997 Medline

Berry T. A selenium transport protein model of a sub-type of schizophrenia. Med. Hypothesis 43: 409-414, 1994 Medline

Brown K, Reid A, White T, et al. Vitamin E, lipids and lipid peroxidation products in tardive dyskinesia. Biol. Psychiatry 43: 863-867, 1998 Medline

Brugge KL, Nichols S, Delis D, et al. The role of alterations in free radical metabolism in mediating cognitive impairments in Down syndrome. EXS 62: 190-198, 1992 Medline

Buckman TD, Kling AS, Eiduson S, et al. Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol. Psychiatry 22: 1349-1356, 1987 Medline

Buckman TD, Kling AS, Sutphin MS, et al. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics and CT scan abnormalities: relation to psychosocial variables. Psychiatry Res. 31: 1-14, 1990 Medline

Cadet TL, Kahler LA. Free radical mechanisms in schizophrenia and tardive diskinesia. Neurosci. Biobehav. Rev. 18: 457-467, 1994 Medline

Clausen J, Jenson GE, Nielsen SA. Selenium in chronic neurological diseases. Multiple sclerosis and Batten’s disease. Biol. Trace Elem. Res. 15: 179-203, 1988 Medline

D’Almeida V, Lobo LL, Hippolide DC, et al. Sleep deprivation induces brain region-specific decreases in glutathione levels. Neuroreport 9: 2853-2856, 1998 Medline

Davey GP, Peuchen S, Clark JB. Energy thresholds in brain mitochondria. Potential involvement in neurodegeneration. J. Biol. Chem. 273: 12753-12757, 1998 Medline

Evans PH. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49: 577-587, 1993 Medline

Fekkes D, Bode WT, Zijlstra FJ, Pepplinkhuizen L. Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms. Prostaglandins Leukot. Essent. Fatty Acids 54: 261-264, 1996 Medline

Govorin NV, Govorin AV, Skuzhutin SA. Significance of disorders of the processes of lipid peroxidation in patients with persistent paranoid schizophrenia resistant to the treatment. Zh. Nevropatol. Psikhiatr. Im. S. S. Korsakova 91: 121-124, 1991 Medline

Honda K, Komoda Y, Inoue S. Oxidized glutathione regulates physiological sleep in unrestrained rats. Brain Res. 636: 253-258, 1994 Medline

Inoue S, Honda K, Komoda Y. Sleep as neuronal detoxification and restitution. Behav. Brain Res. 69: 91-96, 1995 Medline

Kimura M, Kapas L, Krueger JM. Oxidized glutathione promotes sleep in rabbits. Brain Res. Bull. 45: 545-548, 1998 Medline

Jain A, Martensson J, Stole E, et al. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA 88: 1913-1917, 1991 Medline

Jenner P. Oxidative stress in Parkinson’s disease and other neurodegenerative disorders. Pathol. Biol. (Paris) 44: 57-64, 1996 Medline

Jensen GE, Clausen J. Leukocyte glutathione peroxidase activity and selenium level in Batten’s disease. Scand. J. Clin. Lab. Invest. 43: 187-196, 1983 Medline

Lohr JB. Oxygen radicals and neuropsychiatric illness. Some speculations. Arch. Gen. Psychiatry 48: 1097-1106, 1991 Medline

Lohr JB, Browning JA. Free radical involvement in neuropsychiatric illnesses. Psychpharmacol. Bull. 31: 159-165, 1995 Medline

Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids 55: 45-54, 1996 Medline

Mahadik SP, Mukherjee S, Scheffer RE, et al. Elevated plasma lipid peroxidases at the onset of non-affective psychosis. Biol. Psychiatry 43: 674-679, 1998 Medline

Maertens P, Dyken P, Graf W, et al. Free radicals, anticonvulsants, and the neuronal ceroid-lipofuscinoses. American J. Med. Genet. 57: 225-228, 1995 Medline

May PC, Gray PN. The mechanism of glutamate-induced degeneration of cultured Huntington’s disease and control fibroblasts. J. Neurol. Sci. 70: 101-112, 1985 Medline

Mukerjee S, Mahadik SP, Scheffer RE, et al. Impaired antioxidant defense at the onset of psychosis. Schizophr. Res. 19: 19-26, 1996 Medline

Nakagami Y, Saito H, Katsuki H. 3-Hydroxykynurenine toxicity on the rat striatum in vivo. Jpn. J. Pharmacol. 71: 183-186, 1996 Medline

Pai BN, Janakiramaiah N, Gangadhar BN, Ravindranath V. Depletion of glutathione and enhanced lipid peroxidation in the CSF of acute psychotics following haloperidol adminstration. Biol. Psychiatry 36: 489-491, 1994 Medline

Pal SN, Dandiya PC. Glutathione as a cerebral substance in depressive behavior. Pharmacol. Biochem. Behav. 48: 845-851, 1994 Medline

Percy ME, Dalton AJ, Markovic VD, et al. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer’s disease. American J. Med. Genet. 35: 459-467, 1990 Medline

Reddy R, Sahebarao MP, Mukherjee S, Murthy JN. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Bio. Psychiatry 30: 409-412, 1991 Medline

Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review. Prostaglandins Leukot. Essent. Fatty Acids 55: 33-43, 1996 Medline

Reiter RJ. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB 9: 526-533, 1995 Medline

Rotrosen J, Adler L, Edson R, Lavori P. Antioxidant treatment of tardive dyskinesia. Prostaglandins Leukot. Essent. Fatty Acids 55: 77-81, 1996 Medline

Sagara Y. Induction of reactive oxygen species in neurons by haloperidol. J. Neurochem. 71: 1002-1012, 1998 Medline

Schneider RH, Nidich SI, Salerno JW, et al. Lower lipid peroxidase levels in practitioners of the Transcendental Meditation program. Psychosom. Med. 60:38-41, 1998 Medline

Smythies JR. Oxidative reactions and schizophrenia: a review-discussion. Schizophrenic Res. 24: 357-364, 1997 Medline

Stabel-Burow J, Kleu A, Schuchmann S, Heinemann U. Glutathione levels and nerve cell loss in hippocampal cultures from trisomy 16 mouse – a model of Down Syndrome. Brain Res. 765: 313-318, 1997 Medline

Tabrizi SJ, Cleeter MW, Xuereb J, et al. Biochemical abnormalities and excitotoxicity in Huntington’s disease brain. Ann. Neurol. 45: 25-32, 1999 Medline

Teksen F, Sayli BS, Aydin A, et al. Antioxidative metabolism in Down syndrome. Biol. Trace Elem. Res. 63: 123-127, 1998 Medline

Westermarck T, Sandholm M. Decreased erythrocyte glutathione peroxidase activity in neuronal lipofuscinosis (NCL) – corrected with selenium supplementation. Acta. Pharmacol. Toxicol. (Copenh.) 40: 70-74, 1977 Medline

Yao JK, Reddy R, McElhinny LG, Van Kammen DP. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenic. Res. 32: 1-8, 1998 Medline

Yao JK, Reddy R, Van Kammen DP. Human plasma glutathione peroxidase and symptom severity in schizophrenia. Biol. Psychiatry 45: 1512-1515, 1999 Medline

Zanella A, Izzo C, Meola G, et al. Metabolic impairment and membrane abnormality in red cells from from Huntington’s disease. J. Neurol. Sci. 47: 93-103, 1980 Medline